“The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN” (2025) Vascular and Endovascular Review, 8(5s), pp. 154–161. doi:10.64149/J.Ver.8.5s.154-161.